By Foo Yun Chee
Brussels: France-based Cooper Consumer Health on Wednesday secured EU antitrust approval to buy U.S. drugmaker Viatris‘ European over-the-counter drug business after agreeing to sell its rights and interests in an infant laxative medicine and earwax removal product.
The companies announced the $3.6 billion deal last October, with Viatris selling some of its businesses to focus on…
